M.D. Mert Öztaş is a rheumatologist trained at Istanbul University Cerrahpaşa Faculty of Medicine, where he completed his rheumatology specialization in 2021. He currently practices at Acıbadem Health Group (since 2023), providing comprehensive care for patients with inflammatory and autoimmune musculoskeletal conditions. Dr. Öztaş is active in professional development and collaboration. He holds memberships in the Turkish Rheumatology Association and its Young Rheumatologists group (TRD‑G), and participates in EMEUNET (Emerging EULAR Network), connecting with peers across Europe to advance clinical practice and research in rheumatology. He is committed to patient-centered care, evidence-based treatment, and ongoing learning to bring the latest advances in rheumatology to his practice.
Education
- 2021 Istanbul University Cerrahpasa Faculty of Medicine Rheumatology
- 2018 Istanbul University Cerrahpaşa Faculty of Medicine Internal Medicine
- 2012 Istanbul University Cerrahpasa Faculty of Medicine
Experience
- 2023 Acibadem Health Group
- 2021 – 2023 Health Sciences University Istanbul Training and Research Hospital
- 2018 – 2021 Istanbul University Cerrahpasa Medical Faculty, Rheumatology
- 2013 – 2018 Istanbul University Cerrahpasa Faculty of Medicine, Internal Medicine
- 2012 Devrek State Hospital
Memberships
- TRD-G (Turkish Rheumatology Association-Young)
- Turkish Rheumatology Association
- EMEUNET (Emerging EULAR Network)
Publications
- Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience
Int J Rheum Dis. 2023 Jun 26. doi: 10.1111/1756-185X.14798. Oztas M, Altun I, Ayla AY, Cerme E, Demirdag C, Asa S, Sonmezoglu K, Ugurlu S. - Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.
J Med Virol. 2022 Jul;94(7):3431-3437. Oztas M, Bektas M, Karacan I, Aliyeva N, Dag A, Aghamuradov S, Cevirgen SB, Sari S, Bolayirli M, Can G, Hatemi G, Seyahi E, Ozdogan H, Gul A, Ugurlu S - Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center
Turk J Med Sci. 2021 Sep 27. doi: 10.3906/sag-2102-263. Öztaş M, Özgül H, Seyahi E, Uğurlu S. - Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia
Turk J Haematol. 2020 Jul 23. PMID: 32702949. Öztaş M, Muradov İ, Erçalışkan A, Demiröz AS, Batur Ş, Eşkazan AE, Uğurlu S. - Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomized controlled trials.
Clin Exp Rheumatol. 2020 Nov 17. Oztas M, Dincer ZT, Sut N, Yazici H. - Atorvastatin-induced dermatomyositis.
Rheumatol Int. 2017 Jul;37(7):1217-1219. PMID:28238074 Oztas M, Ugurlu S, Aydin O.
